nodes	percent_of_prediction	percent_of_DWPC	metapath
Maraviroc—CCR5—hepatitis B	0.806	1	CbGaD
Maraviroc—CCR5—blood plasma—hepatitis B	0.0169	0.652	CbGeAlD
Maraviroc—CCR5—Binding and entry of HIV virion—CD4—hepatitis B	0.00727	0.181	CbGpPWpGaD
Maraviroc—Hepatic cirrhosis—Entecavir—hepatitis B	0.00706	0.0553	CcSEcCtD
Maraviroc—CCR5—blood—hepatitis B	0.00619	0.239	CbGeAlD
Maraviroc—Depressive disorder—Lamivudine—hepatitis B	0.00463	0.0362	CcSEcCtD
Maraviroc—Dysthymic disorder—Lamivudine—hepatitis B	0.00405	0.0317	CcSEcCtD
Maraviroc—Respiratory disorder—Lamivudine—hepatitis B	0.00405	0.0317	CcSEcCtD
Maraviroc—Respiration abnormal—Lamivudine—hepatitis B	0.00382	0.0299	CcSEcCtD
Maraviroc—Lipodystrophy—Lamivudine—hepatitis B	0.00343	0.0269	CcSEcCtD
Maraviroc—Lipodystrophy acquired—Lamivudine—hepatitis B	0.00299	0.0234	CcSEcCtD
Maraviroc—Basedow's disease—Lamivudine—hepatitis B	0.00287	0.0225	CcSEcCtD
Maraviroc—CCR5—Early Phase of HIV Life Cycle—CD4—hepatitis B	0.00267	0.0663	CbGpPWpGaD
Maraviroc—Muscle atrophy—Lamivudine—hepatitis B	0.00266	0.0208	CcSEcCtD
Maraviroc—Myositis—Telbivudine—hepatitis B	0.00227	0.0177	CcSEcCtD
Maraviroc—Transaminases increased—Entecavir—hepatitis B	0.00222	0.0174	CcSEcCtD
Maraviroc—Creatine phosphokinase increased—Telbivudine—hepatitis B	0.00211	0.0166	CcSEcCtD
Maraviroc—Autoimmune disorder—Lamivudine—hepatitis B	0.00188	0.0147	CcSEcCtD
Maraviroc—CCR5—Chemokine receptors bind chemokines—CXCL10—hepatitis B	0.00181	0.0449	CbGpPWpGaD
Maraviroc—CYP3A4—blood plasma—hepatitis B	0.0017	0.0658	CbGeAlD
Maraviroc—Blood creatine phosphokinase increased—Telbivudine—hepatitis B	0.00162	0.0126	CcSEcCtD
Maraviroc—Opportunistic infection—Lamivudine—hepatitis B	0.00156	0.0122	CcSEcCtD
Maraviroc—CCR5—HIV Infection—APOBEC3G—hepatitis B	0.00155	0.0387	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—IL18—hepatitis B	0.00147	0.0366	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—CD8A—hepatitis B	0.00145	0.0361	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—FASLG—hepatitis B	0.00136	0.0339	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—HLA-A—hepatitis B	0.00129	0.0321	CbGpPWpGaD
Maraviroc—Rhabdomyolysis—Telbivudine—hepatitis B	0.00126	0.00984	CcSEcCtD
Maraviroc—Creatine phosphokinase increased—Lamivudine—hepatitis B	0.00119	0.00933	CcSEcCtD
Maraviroc—CCR5—IL12-mediated signaling events—HLA-DRB1—hepatitis B	0.00118	0.0294	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—NOS2—hepatitis B	0.00112	0.028	CbGpPWpGaD
Maraviroc—Hepatic failure—Entecavir—hepatitis B	0.00109	0.00856	CcSEcCtD
Maraviroc—Influenza like illness—Telbivudine—hepatitis B	0.00108	0.00845	CcSEcCtD
Maraviroc—Hepatic failure—Adefovir Dipivoxil—hepatitis B	0.00107	0.00835	CcSEcCtD
Maraviroc—CCR5—TCR Signaling Pathway—CD8A—hepatitis B	0.00105	0.0261	CbGpPWpGaD
Maraviroc—Folliculitis—Lamivudine—hepatitis B	0.000997	0.0078	CcSEcCtD
Maraviroc—Respiratory tract infection—Lamivudine—hepatitis B	0.000997	0.0078	CcSEcCtD
Maraviroc—CCR5—TCR Signaling Pathway—FAS—hepatitis B	0.000951	0.0236	CbGpPWpGaD
Maraviroc—Bone marrow depression—Lamivudine—hepatitis B	0.000928	0.00727	CcSEcCtD
Maraviroc—Blood creatine phosphokinase increased—Lamivudine—hepatitis B	0.00091	0.00713	CcSEcCtD
Maraviroc—Abdominal pain upper—Entecavir—hepatitis B	0.000897	0.00703	CcSEcCtD
Maraviroc—CCR5—IL12-mediated signaling events—IFNG—hepatitis B	0.000862	0.0214	CbGpPWpGaD
Maraviroc—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.000845	0.00662	CcSEcCtD
Maraviroc—CCR5—IL12-mediated signaling events—CD4—hepatitis B	0.000833	0.0207	CbGpPWpGaD
Maraviroc—Pancreatitis—Entecavir—hepatitis B	0.000832	0.00652	CcSEcCtD
Maraviroc—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.000812	0.00636	CcSEcCtD
Maraviroc—Neutropenia—Entecavir—hepatitis B	0.000794	0.00622	CcSEcCtD
Maraviroc—Upper respiratory tract infection—Entecavir—hepatitis B	0.000789	0.00618	CcSEcCtD
Maraviroc—CCR5—IL12-mediated signaling events—IL2—hepatitis B	0.000766	0.0191	CbGpPWpGaD
Maraviroc—Acne—Lamivudine—hepatitis B	0.000744	0.00583	CcSEcCtD
Maraviroc—Renal failure—Entecavir—hepatitis B	0.000744	0.00583	CcSEcCtD
Maraviroc—Abdominal pain upper—Telbivudine—hepatitis B	0.000737	0.00577	CcSEcCtD
Maraviroc—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.000727	0.00569	CcSEcCtD
Maraviroc—Renal failure—Adefovir Dipivoxil—hepatitis B	0.000726	0.00569	CcSEcCtD
Maraviroc—Nasopharyngitis—Telbivudine—hepatitis B	0.000722	0.00565	CcSEcCtD
Maraviroc—Jaundice—Adefovir Dipivoxil—hepatitis B	0.00072	0.00564	CcSEcCtD
Maraviroc—CCR5—IL12-mediated signaling events—NFKB1—hepatitis B	0.000718	0.0178	CbGpPWpGaD
Maraviroc—Hepatobiliary disease—Entecavir—hepatitis B	0.000716	0.00561	CcSEcCtD
Maraviroc—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.000712	0.00557	CcSEcCtD
Maraviroc—Rhabdomyolysis—Lamivudine—hepatitis B	0.000708	0.00554	CcSEcCtD
Maraviroc—CYP3A4—Aflatoxin activation and detoxification—GGT2—hepatitis B	0.000703	0.0175	CbGpPWpGaD
Maraviroc—Abdominal distension—Telbivudine—hepatitis B	0.000702	0.0055	CcSEcCtD
Maraviroc—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.000698	0.00547	CcSEcCtD
Maraviroc—Influenza—Telbivudine—hepatitis B	0.000697	0.00546	CcSEcCtD
Maraviroc—Rectal haemorrhage—Lamivudine—hepatitis B	0.000694	0.00543	CcSEcCtD
Maraviroc—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.000693	0.00543	CcSEcCtD
Maraviroc—CCR5—Peptide ligand-binding receptors—CXCL10—hepatitis B	0.00068	0.0169	CbGpPWpGaD
Maraviroc—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.000658	0.00515	CcSEcCtD
Maraviroc—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.000655	0.00513	CcSEcCtD
Maraviroc—CYP3A4—Farnesoid X Receptor  Pathway—NR0B2—hepatitis B	0.000653	0.0162	CbGpPWpGaD
Maraviroc—Neutropenia—Telbivudine—hepatitis B	0.000652	0.00511	CcSEcCtD
Maraviroc—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.000651	0.0051	CcSEcCtD
Maraviroc—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00065	0.00509	CcSEcCtD
Maraviroc—Upper respiratory tract infection—Telbivudine—hepatitis B	0.000648	0.00508	CcSEcCtD
Maraviroc—Inflammation—Lamivudine—hepatitis B	0.000646	0.00506	CcSEcCtD
Maraviroc—Vasculitis—Lamivudine—hepatitis B	0.000642	0.00503	CcSEcCtD
Maraviroc—CYP3A4—blood—hepatitis B	0.000624	0.0241	CbGeAlD
Maraviroc—Renal failure—Telbivudine—hepatitis B	0.000611	0.00479	CcSEcCtD
Maraviroc—Neuropathy peripheral—Telbivudine—hepatitis B	0.00061	0.00477	CcSEcCtD
Maraviroc—CCR5—TCR Signaling Pathway—CD4—hepatitis B	0.000602	0.015	CbGpPWpGaD
Maraviroc—Alopecia—Entecavir—hepatitis B	0.0006	0.0047	CcSEcCtD
Maraviroc—Mental disorder—Entecavir—hepatitis B	0.000595	0.00466	CcSEcCtD
Maraviroc—Malnutrition—Entecavir—hepatitis B	0.000592	0.00463	CcSEcCtD
Maraviroc—Hepatobiliary disease—Telbivudine—hepatitis B	0.000588	0.00461	CcSEcCtD
Maraviroc—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.000577	0.00452	CcSEcCtD
Maraviroc—CCR5—G alpha (i) signalling events—CXCL10—hepatitis B	0.000574	0.0143	CbGpPWpGaD
Maraviroc—Flatulence—Adefovir Dipivoxil—hepatitis B	0.000569	0.00445	CcSEcCtD
Maraviroc—Urine output increased—Lamivudine—hepatitis B	0.000566	0.00444	CcSEcCtD
Maraviroc—Pharyngitis—Telbivudine—hepatitis B	0.000554	0.00434	CcSEcCtD
Maraviroc—Connective tissue disorder—Telbivudine—hepatitis B	0.000549	0.0043	CcSEcCtD
Maraviroc—Anaemia—Adefovir Dipivoxil—hepatitis B	0.000533	0.00418	CcSEcCtD
Maraviroc—Lymphadenopathy—Lamivudine—hepatitis B	0.000533	0.00417	CcSEcCtD
Maraviroc—Leukopenia—Entecavir—hepatitis B	0.000529	0.00415	CcSEcCtD
Maraviroc—Sleep disorder—Lamivudine—hepatitis B	0.000525	0.00411	CcSEcCtD
Maraviroc—CCR5—TCR Signaling Pathway—NFKB1—hepatitis B	0.000519	0.0129	CbGpPWpGaD
Maraviroc—Polyuria—Lamivudine—hepatitis B	0.000518	0.00406	CcSEcCtD
Maraviroc—Deafness—Lamivudine—hepatitis B	0.000508	0.00398	CcSEcCtD
Maraviroc—Cough—Adefovir Dipivoxil—hepatitis B	0.000504	0.00394	CcSEcCtD
Maraviroc—Mediastinal disorder—Telbivudine—hepatitis B	0.000503	0.00394	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.0005	0.00392	CcSEcCtD
Maraviroc—Myalgia—Adefovir Dipivoxil—hepatitis B	0.000491	0.00385	CcSEcCtD
Maraviroc—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—hepatitis B	0.000488	0.0121	CbGpPWpGaD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.000488	0.00382	CcSEcCtD
Maraviroc—CYP3A4—liver—hepatitis B	0.000488	0.0188	CbGeAlD
Maraviroc—Malnutrition—Telbivudine—hepatitis B	0.000486	0.00381	CcSEcCtD
Maraviroc—Infection—Entecavir—hepatitis B	0.00048	0.00376	CcSEcCtD
Maraviroc—Nervous system disorder—Entecavir—hepatitis B	0.000473	0.00371	CcSEcCtD
Maraviroc—Skin disorder—Entecavir—hepatitis B	0.000469	0.00367	CcSEcCtD
Maraviroc—CCR5—HIV Infection—HLA-A—hepatitis B	0.000464	0.0115	CbGpPWpGaD
Maraviroc—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.000462	0.00362	CcSEcCtD
Maraviroc—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.000458	0.00358	CcSEcCtD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	0.000456	0.0113	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—F2—hepatitis B	0.000453	0.0113	CbGpPWpGaD
Maraviroc—Anorexia—Adefovir Dipivoxil—hepatitis B	0.000449	0.00352	CcSEcCtD
Maraviroc—Insomnia—Entecavir—hepatitis B	0.000437	0.00342	CcSEcCtD
Maraviroc—CCR5—HIV Life Cycle—CD4—hepatitis B	0.000433	0.0108	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—TGFB1—hepatitis B	0.000432	0.0107	CbGpPWpGaD
Maraviroc—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.000429	0.00336	CcSEcCtD
Maraviroc—Cough—Telbivudine—hepatitis B	0.000424	0.00332	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Entecavir—hepatitis B	0.000417	0.00326	CcSEcCtD
Maraviroc—Fatigue—Entecavir—hepatitis B	0.000416	0.00326	CcSEcCtD
Maraviroc—Abdominal pain upper—Lamivudine—hepatitis B	0.000415	0.00325	CcSEcCtD
Maraviroc—Myalgia—Telbivudine—hepatitis B	0.000414	0.00324	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.000411	0.00322	CcSEcCtD
Maraviroc—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.000409	0.00321	CcSEcCtD
Maraviroc—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.000409	0.00321	CcSEcCtD
Maraviroc—Discomfort—Telbivudine—hepatitis B	0.000409	0.0032	CcSEcCtD
Maraviroc—CYP3A4—Xenobiotics—CYP2A6—hepatitis B	0.000409	0.0102	CbGpPWpGaD
Maraviroc—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.000407	0.00318	CcSEcCtD
Maraviroc—Nasopharyngitis—Lamivudine—hepatitis B	0.000407	0.00318	CcSEcCtD
Maraviroc—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.000401	0.00314	CcSEcCtD
Maraviroc—Abdominal distension—Lamivudine—hepatitis B	0.000396	0.0031	CcSEcCtD
Maraviroc—Gastrointestinal pain—Entecavir—hepatitis B	0.000395	0.00309	CcSEcCtD
Maraviroc—Influenza—Lamivudine—hepatitis B	0.000393	0.00308	CcSEcCtD
Maraviroc—CYP3A4—Tamoxifen metabolism—CYP2A6—hepatitis B	0.000393	0.00977	CbGpPWpGaD
Maraviroc—Nervous system disorder—Telbivudine—hepatitis B	0.000389	0.00305	CcSEcCtD
Maraviroc—Pancreatitis—Lamivudine—hepatitis B	0.000385	0.00302	CcSEcCtD
Maraviroc—Skin disorder—Telbivudine—hepatitis B	0.000385	0.00302	CcSEcCtD
Maraviroc—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.000385	0.00302	CcSEcCtD
Maraviroc—Body temperature increased—Entecavir—hepatitis B	0.000382	0.00299	CcSEcCtD
Maraviroc—Abdominal pain—Entecavir—hepatitis B	0.000382	0.00299	CcSEcCtD
Maraviroc—CCR5—Disease—APOBEC3G—hepatitis B	0.000381	0.00947	CbGpPWpGaD
Maraviroc—CCR5—Disease—SAG—hepatitis B	0.000381	0.00947	CbGpPWpGaD
Maraviroc—Bronchitis—Lamivudine—hepatitis B	0.000378	0.00296	CcSEcCtD
Maraviroc—Pancytopenia—Lamivudine—hepatitis B	0.000373	0.00292	CcSEcCtD
Maraviroc—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.000372	0.00292	CcSEcCtD
Maraviroc—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.000372	0.00292	CcSEcCtD
Maraviroc—Neutropenia—Lamivudine—hepatitis B	0.000368	0.00288	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.000361	0.00283	CcSEcCtD
Maraviroc—Insomnia—Telbivudine—hepatitis B	0.000359	0.00281	CcSEcCtD
Maraviroc—Paraesthesia—Telbivudine—hepatitis B	0.000356	0.00279	CcSEcCtD
Maraviroc—Depression—Lamivudine—hepatitis B	0.000349	0.00274	CcSEcCtD
Maraviroc—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.000347	0.00272	CcSEcCtD
Maraviroc—CCR5—GPCR ligand binding—CXCL10—hepatitis B	0.000347	0.00864	CbGpPWpGaD
Maraviroc—Asthenia—Entecavir—hepatitis B	0.000346	0.00271	CcSEcCtD
Maraviroc—Renal failure—Lamivudine—hepatitis B	0.000344	0.0027	CcSEcCtD
Maraviroc—Neuropathy peripheral—Lamivudine—hepatitis B	0.000343	0.00269	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Telbivudine—hepatitis B	0.000342	0.00268	CcSEcCtD
Maraviroc—Fatigue—Telbivudine—hepatitis B	0.000342	0.00268	CcSEcCtD
Maraviroc—Stomatitis—Lamivudine—hepatitis B	0.000342	0.00267	CcSEcCtD
Maraviroc—Jaundice—Lamivudine—hepatitis B	0.000342	0.00267	CcSEcCtD
Maraviroc—Pain—Telbivudine—hepatitis B	0.000339	0.00266	CcSEcCtD
Maraviroc—Asthenia—Adefovir Dipivoxil—hepatitis B	0.000338	0.00265	CcSEcCtD
Maraviroc—Pruritus—Adefovir Dipivoxil—hepatitis B	0.000333	0.00261	CcSEcCtD
Maraviroc—CYP3A4—Aflatoxin activation and detoxification—GGT1—hepatitis B	0.000332	0.00826	CbGpPWpGaD
Maraviroc—Hepatobiliary disease—Lamivudine—hepatitis B	0.000331	0.0026	CcSEcCtD
Maraviroc—Diarrhoea—Entecavir—hepatitis B	0.00033	0.00259	CcSEcCtD
Maraviroc—Sinusitis—Lamivudine—hepatitis B	0.000329	0.00257	CcSEcCtD
Maraviroc—Agranulocytosis—Lamivudine—hepatitis B	0.000327	0.00256	CcSEcCtD
Maraviroc—CCR5—TCR Signaling Pathway—IL6—hepatitis B	0.000326	0.0081	CbGpPWpGaD
Maraviroc—Gastrointestinal pain—Telbivudine—hepatitis B	0.000324	0.00254	CcSEcCtD
Maraviroc—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.000322	0.00252	CcSEcCtD
Maraviroc—Dizziness—Entecavir—hepatitis B	0.000319	0.0025	CcSEcCtD
Maraviroc—Rhinitis—Lamivudine—hepatitis B	0.000315	0.00247	CcSEcCtD
Maraviroc—Body temperature increased—Telbivudine—hepatitis B	0.000314	0.00246	CcSEcCtD
Maraviroc—Abdominal pain—Telbivudine—hepatitis B	0.000314	0.00246	CcSEcCtD
Maraviroc—Pharyngitis—Lamivudine—hepatitis B	0.000312	0.00245	CcSEcCtD
Maraviroc—Connective tissue disorder—Lamivudine—hepatitis B	0.000309	0.00242	CcSEcCtD
Maraviroc—Vomiting—Entecavir—hepatitis B	0.000307	0.0024	CcSEcCtD
Maraviroc—Rash—Entecavir—hepatitis B	0.000304	0.00238	CcSEcCtD
Maraviroc—Dermatitis—Entecavir—hepatitis B	0.000304	0.00238	CcSEcCtD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	0.000304	0.00755	CbGpPWpGaD
Maraviroc—Headache—Entecavir—hepatitis B	0.000302	0.00237	CcSEcCtD
Maraviroc—Vomiting—Adefovir Dipivoxil—hepatitis B	0.000299	0.00235	CcSEcCtD
Maraviroc—CCR5—HIV Infection—CD4—hepatitis B	0.000299	0.00743	CbGpPWpGaD
Maraviroc—Erythema multiforme—Lamivudine—hepatitis B	0.000297	0.00233	CcSEcCtD
Maraviroc—Rash—Adefovir Dipivoxil—hepatitis B	0.000297	0.00233	CcSEcCtD
Maraviroc—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.000297	0.00232	CcSEcCtD
Maraviroc—Headache—Adefovir Dipivoxil—hepatitis B	0.000295	0.00231	CcSEcCtD
Maraviroc—Nausea—Entecavir—hepatitis B	0.000287	0.00225	CcSEcCtD
Maraviroc—Asthenia—Telbivudine—hepatitis B	0.000285	0.00223	CcSEcCtD
Maraviroc—Mediastinal disorder—Lamivudine—hepatitis B	0.000284	0.00222	CcSEcCtD
Maraviroc—Pruritus—Telbivudine—hepatitis B	0.000281	0.0022	CcSEcCtD
Maraviroc—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00028	0.00697	CbGpPWpGaD
Maraviroc—Nausea—Adefovir Dipivoxil—hepatitis B	0.00028	0.00219	CcSEcCtD
Maraviroc—Alopecia—Lamivudine—hepatitis B	0.000278	0.00218	CcSEcCtD
Maraviroc—Erythema—Lamivudine—hepatitis B	0.000274	0.00214	CcSEcCtD
Maraviroc—Malnutrition—Lamivudine—hepatitis B	0.000274	0.00214	CcSEcCtD
Maraviroc—Diarrhoea—Telbivudine—hepatitis B	0.000271	0.00212	CcSEcCtD
Maraviroc—Flatulence—Lamivudine—hepatitis B	0.00027	0.00211	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—RIT2—hepatitis B	0.000267	0.00663	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—SAG—hepatitis B	0.000267	0.00663	CbGpPWpGaD
Maraviroc—Dizziness—Telbivudine—hepatitis B	0.000262	0.00205	CcSEcCtD
Maraviroc—Tremor—Lamivudine—hepatitis B	0.000257	0.00201	CcSEcCtD
Maraviroc—Anaemia—Lamivudine—hepatitis B	0.000253	0.00198	CcSEcCtD
Maraviroc—Vomiting—Telbivudine—hepatitis B	0.000252	0.00197	CcSEcCtD
Maraviroc—Rash—Telbivudine—hepatitis B	0.00025	0.00196	CcSEcCtD
Maraviroc—Dermatitis—Telbivudine—hepatitis B	0.00025	0.00196	CcSEcCtD
Maraviroc—Headache—Telbivudine—hepatitis B	0.000248	0.00195	CcSEcCtD
Maraviroc—Syncope—Lamivudine—hepatitis B	0.000246	0.00192	CcSEcCtD
Maraviroc—Leukopenia—Lamivudine—hepatitis B	0.000245	0.00192	CcSEcCtD
Maraviroc—Loss of consciousness—Lamivudine—hepatitis B	0.000241	0.00188	CcSEcCtD
Maraviroc—Cough—Lamivudine—hepatitis B	0.000239	0.00187	CcSEcCtD
Maraviroc—Convulsion—Lamivudine—hepatitis B	0.000237	0.00186	CcSEcCtD
Maraviroc—Nausea—Telbivudine—hepatitis B	0.000236	0.00184	CcSEcCtD
Maraviroc—Myalgia—Lamivudine—hepatitis B	0.000233	0.00183	CcSEcCtD
Maraviroc—Anxiety—Lamivudine—hepatitis B	0.000232	0.00182	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.000232	0.00181	CcSEcCtD
Maraviroc—CCR5—GPCR ligand binding—F2—hepatitis B	0.000231	0.00575	CbGpPWpGaD
Maraviroc—Discomfort—Lamivudine—hepatitis B	0.00023	0.0018	CcSEcCtD
Maraviroc—Oedema—Lamivudine—hepatitis B	0.000223	0.00175	CcSEcCtD
Maraviroc—Infection—Lamivudine—hepatitis B	0.000222	0.00174	CcSEcCtD
Maraviroc—Shock—Lamivudine—hepatitis B	0.00022	0.00172	CcSEcCtD
Maraviroc—Nervous system disorder—Lamivudine—hepatitis B	0.000219	0.00172	CcSEcCtD
Maraviroc—Skin disorder—Lamivudine—hepatitis B	0.000217	0.0017	CcSEcCtD
Maraviroc—Anorexia—Lamivudine—hepatitis B	0.000213	0.00167	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.000204	0.00159	CcSEcCtD
Maraviroc—Insomnia—Lamivudine—hepatitis B	0.000202	0.00158	CcSEcCtD
Maraviroc—Paraesthesia—Lamivudine—hepatitis B	0.000201	0.00157	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—CXCL10—hepatitis B	0.000196	0.00488	CbGpPWpGaD
Maraviroc—Decreased appetite—Lamivudine—hepatitis B	0.000194	0.00152	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Lamivudine—hepatitis B	0.000193	0.00151	CcSEcCtD
Maraviroc—Fatigue—Lamivudine—hepatitis B	0.000193	0.00151	CcSEcCtD
Maraviroc—Constipation—Lamivudine—hepatitis B	0.000191	0.0015	CcSEcCtD
Maraviroc—Pain—Lamivudine—hepatitis B	0.000191	0.0015	CcSEcCtD
Maraviroc—Gastrointestinal pain—Lamivudine—hepatitis B	0.000183	0.00143	CcSEcCtD
Maraviroc—CCR5—Disease—GOT2—hepatitis B	0.000181	0.0045	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CXCL10—hepatitis B	0.000178	0.00443	CbGpPWpGaD
Maraviroc—Abdominal pain—Lamivudine—hepatitis B	0.000177	0.00138	CcSEcCtD
Maraviroc—Body temperature increased—Lamivudine—hepatitis B	0.000177	0.00138	CcSEcCtD
Maraviroc—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.00017	0.00422	CbGpPWpGaD
Maraviroc—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000167	0.00416	CbGpPWpGaD
Maraviroc—Hypersensitivity—Lamivudine—hepatitis B	0.000165	0.00129	CcSEcCtD
Maraviroc—Asthenia—Lamivudine—hepatitis B	0.00016	0.00126	CcSEcCtD
Maraviroc—Pruritus—Lamivudine—hepatitis B	0.000158	0.00124	CcSEcCtD
Maraviroc—CCR5—Disease—GOT1—hepatitis B	0.000156	0.00388	CbGpPWpGaD
Maraviroc—Diarrhoea—Lamivudine—hepatitis B	0.000153	0.0012	CcSEcCtD
Maraviroc—Dizziness—Lamivudine—hepatitis B	0.000148	0.00116	CcSEcCtD
Maraviroc—Vomiting—Lamivudine—hepatitis B	0.000142	0.00111	CcSEcCtD
Maraviroc—Rash—Lamivudine—hepatitis B	0.000141	0.0011	CcSEcCtD
Maraviroc—Dermatitis—Lamivudine—hepatitis B	0.000141	0.0011	CcSEcCtD
Maraviroc—Headache—Lamivudine—hepatitis B	0.00014	0.0011	CcSEcCtD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000138	0.00342	CbGpPWpGaD
Maraviroc—Nausea—Lamivudine—hepatitis B	0.000133	0.00104	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—F2—hepatitis B	0.000131	0.00325	CbGpPWpGaD
Maraviroc—CYP3A4—Metapathway biotransformation—AKR1B1—hepatitis B	0.000124	0.00308	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—GGT2—hepatitis B	0.000121	0.003	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—F2—hepatitis B	0.000119	0.00295	CbGpPWpGaD
Maraviroc—CCR5—Disease—HLA-A—hepatitis B	0.000114	0.00283	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CXCL10—hepatitis B	0.000105	0.00262	CbGpPWpGaD
Maraviroc—CCR5—Disease—NOS2—hepatitis B	9.89e-05	0.00246	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—IL2—hepatitis B	8.8e-05	0.00219	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—IL2—hepatitis B	7.99e-05	0.00199	CbGpPWpGaD
Maraviroc—CCR5—Disease—CD4—hepatitis B	7.32e-05	0.00182	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—CYP2A6—hepatitis B	7.31e-05	0.00182	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—F2—hepatitis B	7.01e-05	0.00174	CbGpPWpGaD
Maraviroc—CCR5—Disease—CTNNB1—hepatitis B	6.51e-05	0.00162	CbGpPWpGaD
Maraviroc—CCR5—Disease—CDKN1A—hepatitis B	6.36e-05	0.00158	CbGpPWpGaD
Maraviroc—CCR5—Disease—PTEN—hepatitis B	6.34e-05	0.00158	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—GGT1—hepatitis B	5.7e-05	0.00142	CbGpPWpGaD
Maraviroc—CCR5—Disease—TGFB1—hepatitis B	5.26e-05	0.00131	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IL2—hepatitis B	4.72e-05	0.00117	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—IL6—hepatitis B	4.7e-05	0.00117	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CTNNB1—hepatitis B	4.56e-05	0.00113	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CDKN1A—hepatitis B	4.45e-05	0.00111	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PTEN—hepatitis B	4.44e-05	0.0011	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—NFKB1—hepatitis B	4.42e-05	0.0011	CbGpPWpGaD
Maraviroc—CCR5—Disease—IL6—hepatitis B	3.96e-05	0.000985	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—TGFB1—hepatitis B	3.68e-05	0.000915	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—TP53—hepatitis B	3.03e-05	0.000753	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IL6—hepatitis B	2.77e-05	0.00069	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—AKR1B1—hepatitis B	2.15e-05	0.000535	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GGT2—hepatitis B	2.06e-05	0.000513	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CYP2A6—hepatitis B	1.25e-05	0.000311	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GOT2—hepatitis B	1.13e-05	0.000281	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GGT1—hepatitis B	9.75e-06	0.000242	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GOT1—hepatitis B	9.75e-06	0.000242	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ALB—hepatitis B	5.19e-06	0.000129	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PTEN—hepatitis B	3.96e-06	9.84e-05	CbGpPWpGaD
